UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 9, 2011
BIOJECT MEDICAL TECHNOLOGIES INC.
(Exact name of registrant as specified in its charter)
Commission File Number: 000-15360
| Oregon | 93-1099680 | |
| (State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) | |
| 20245 SW 95th Avenue Tualatin, Oregon |
97062 | |
| (Address of principal executive offices) | (Zip Code) | |
Registrant’s telephone number, including area code: (503) 692-8001
Former name or former address if changed since last report: No Change
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.07 Submission of Matters to a Vote of Security Holders.
On June 9, 2011, Bioject Medical Technologies Inc. (the “Company”) held its Annual Meeting of Shareholders. The matters voted upon at the meeting included (i) the election of two members of the Board of Directors for one-year terms; and (ii) the ratification of Moss Adams LLP as the Company’s Independent Registered Public Accountant for the year ending December 31, 2011.
Our inspector of elections reported the vote of the shareholders as follows:
| 1. | Election of Directors |
| Director Name |
Class |
Votes For |
Votes Withheld |
Broker Non-Votes | ||||
| Al Hansen |
III | 23,056,998 | 143,973 | 8,747,756 | ||||
| Mark Logomasini |
III | 23,059,798 | 141,173 | 8,747,756 |
| 2. | Ratification of Moss Adams LLP as Independent Registered Public Accountant for the Year Ending December 31, 2011 |
| Votes For |
Votes Against |
Abstentions |
Broker Non-Votes | |||
| 31,812,590 |
125,698 | 10,439 | — |
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: June 14, 2011 | BIOJECT MEDICAL TECHNOLOGIES INC. (Registrant) | |
| /s/ Christine M. Farrell Christine M. Farrell Vice President of Finance (Principal Financial and Accounting Officer) | ||
2